Table 2 Association of KCNJ16 mRNA expression with different variables of thyroid tumor patients

Gender

 Female

50(74)

0.08296(0.05275, 0.1277)

0.56

 Male

18(26)

0.06787(0.04606, 0.1108)

Age/yr

 <55

56(82)

0.08515(0.05309, 0.1255)

0.13

 ≥55

12(18)

0.06295(0.01532, 0.1223)

Tumor diameter/cm

 ≤2

58(85)

0.07784(0.05204, 0.1241)

0.86

 >2

10(15)

0.08093(0.05070, 0.1331)

Histological types

 Benign

6(9)

0.08436(0.04653, 0.1111)

0.43

 PTC^a

36(53)

0.06598(0.04574, 0.1220)

 PTMC^b

26(38)

0.08296(0.05831, 0.1414)

Lymph node metastasis

 Yes

41(60)

0.08668(0.04913, 0.1305)

0.58

 No

27(40)

0.06807(0.05294, 0.1219)

Vascular/capsular invasion

 Yes

28(41)

0.06485(0.04078, 0.1002)

0.02 ^*

 No

40(59)

0.08949(0.05475, 0.1527)

BRAF V600E

 Wild type

21(31)

0.08361(0.05431, 0.1176)

0.82

 Mutation

47(69)

0.07322(0.05159, 0.1303)

Stage

 Stage I

57(84)

0.08232(0.05325, 0.1305)

0.07

 Stage II+III

5(7)

0.02196(0.007871, 0.1285)